Literature DB >> 6877780

Evaluation of a patient with central retinal vein occlusion.

F A Gutman.   

Abstract

Patients suffering a central retinal vein occlusion should be evaluated for conditions that promote and/or contribute to the formation of a thrombosis in the central retinal vein. These conditions include alterations of blood flow, altered viscosity of the blood, abnormalities of coagulation, and abnormalities of vessel walls. Patients with either a partial or complete central retinal vein occlusion have similarities in the age of onset, associated systemic findings, and laboratory data. At the time of onset, 90% of patients are older than 50 years. Seventy-four percent of patients will have symptoms or signs of associated systemic vascular disease (ie, hypertension, arteriosclerotic heart disease, and diabetes mellitus.) The most common laboratory findings include elevated blood lipids, abnormalities of glucose tolerance testing, and abnormalities of protein chemistries. Evaluation should include both a complete ocular and medical examination with appropriate laboratory tests and special studies. Assessment of central retinal venous pressure may be helpful in identifying those patients who have a severe, complete thrombosis and are at significant risk to develop anterior segment neovascularization.

Entities:  

Mesh:

Year:  1983        PMID: 6877780     DOI: 10.1016/s0161-6420(83)34528-0

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  16 in total

1.  Rod and cone a-waves in central retinal vein occlusion.

Authors:  Naoyuki Tanimoto; Tomoaki Usui; Mikio Ichibe; Mineo Takagi; Keiko Suzuki; Shigeru Hasegawa; Haruki Abe
Journal:  Jpn J Ophthalmol       Date:  2005 Sep-Oct       Impact factor: 2.447

2.  Cyclic variation in onset of central retinal vein occlusion.

Authors:  M J Lavin; B J Dhillon
Journal:  Br J Ophthalmol       Date:  1987-01       Impact factor: 4.638

3.  Clinical progress in impending central retinal vein occlusion.

Authors:  Dong-Hoon Lee; Seok-Joon Lee; Ie-Na Yoon
Journal:  Korean J Ophthalmol       Date:  2010-04-06

4.  Pseudoexfoliation and glaucoma in eyes with retinal vein occlusion.

Authors:  O A Saatci; S T Ferliel; M Ferliel; S Kaynak; M H Ergin
Journal:  Int Ophthalmol       Date:  1999       Impact factor: 2.031

5.  Follow up by colour Doppler imaging of 102 patients with retinal vein occlusion over 1 year.

Authors:  S Arséne; B Giraudeau; M-L Le Lez; P J Pisella; L Pourcelot; F Tranquart
Journal:  Br J Ophthalmol       Date:  2002-11       Impact factor: 4.638

6.  Long-term effects of radial optic neurotomy for central retinal vein occlusion consecutive interventional case series.

Authors:  Susanne Binder; Tina Aggermann; Simon Brunner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-04-04       Impact factor: 3.117

7.  Thrombolytic therapy for central retinal vein occlusion: results of a pilot study.

Authors:  M J Elman
Journal:  Trans Am Ophthalmol Soc       Date:  1996

8.  Central retinal vein occlusion in a young Chinese population: risk factors and associated morbidity and mortality.

Authors:  Jane Zea-Chin Kuo; Chi-Chun Lai; Frank Shih-Chang Ong; Chia-Pang Shih; Ling Yeung; Tun-Lu Chen; Kuan-Jen Chen; Wei-Chi Wu
Journal:  Retina       Date:  2010-03       Impact factor: 4.256

9.  Differentiation of ischemic from non-ischemic central retinal vein occlusion during the early acute phase.

Authors:  S S Hayreh; M R Klugman; M Beri; A E Kimura; P Podhajsky
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

10.  A prospective, randomised, multicenter trial for surgical treatment of central retinal vein occlusion: results of the Radial Optic Neurotomy for Central Vein Occlusion (ROVO) study group.

Authors:  Tina Aggermann; Simon Brunner; Ilse Krebs; Paulina Haas; Irene Womastek; Werner Brannath; Susanne Binder
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-09-08       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.